1.
Semaglutide Protects Retinal Ganglion Cells Against Rotenone-Induced Degeneration via Improved Glucose Metabolism.
Mouhammad Zaynab A, Tribble James R, Nicol Alan, Andreopoulou Evgenia, García-Bermúdez Mariana Y, Aldana Blanca I et al.
Invest Ophthalmol Vis SciFeb 20260 citationsBasic Science
Semaglutide protected retinal ganglion cells from degeneration in a glaucoma model by enhancing retinal glucose metabolism, suggesting a potential neuroprotective strategy for glaucoma via metabolic flexibility.